Efficacy and effectiveness of long-acting monoclonal antibodies and vaccines against RSV: a systematic review and meta-analysis of studies from 2018 to 2025Research in context

Summary: Background: Respiratory syncytial virus (RSV) remains a leading cause of lower respiratory tract infection (LRTI) and mortality among infants and older adults globally. The recent approval of long-acting monoclonal antibodies (mAbs) and prefusion F protein-based vaccines marks a significan...

Повний опис

Бібліографічні деталі

Автори:	Jiayi Du, Sophie Li, Ivan F.N. Hung, Joseph T. Wu, Kathy Leung
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Elsevier 2026-06-01
Серія:	EClinicalMedicine
Предмети:	Respiratory syncytial virus RSV monoclonal antibodies RSV vaccines Meta-analysis
Онлайн доступ:	http://www.sciencedirect.com/science/article/pii/S258953702600266X
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!